In 2024, the global plasma fractionation market was valued at USD 29.76 billion, and projections anticipate growth at a compound annual growth rate of 6.5 % during the forecast window. Within that overarching expansion, the concentration of revenue, innovation and policy influence in a handful of countries—particularly the United States, Germany, China, and Japan—drives how the...

  The influencing factors of Medical Tourism include promoting factors and hindering factors. Promoting factors for the development of Medical Tourism: One is the difference in medical expenses and the waiting time for treatment. This is the main factor that prompts many foreign patients to seek medical services in developing countries. For instance, Kittikanya's research found that...

Executive Summary Bickers Adams Edwards Syndrome Market Value, Size, Share and Projections CAGR Value The bickers adams edwards syndrome market is expected to gain growth at a potential rate of 4.80% in the forecast period of 2021 to 2028 The top notch Bickers Adams Edwards Syndrome Market report explains current and future market trends and carries out analysis of the impact...

The Europe Clinical Laboratory Tests Market, valued at USD 68.54 billion in 2024, is expected to grow at a CAGR of 2.21% during 2025–2034, reaching USD 85.21 billion by 2034. The market growth is fueled by the increasing adoption of molecular diagnostics, expansion of laboratory automation, and growing investment in healthcare infrastructure across Europe. The...

Market Size and Growth The global rare disease drugs market is projected to reach around $217 billion in 2025 and is expected to grow at a compound annual growth rate (CAGR) ranging from 8.5% to nearly 12% between 2025 and 2034. Various estimates project market valuations between $217 billion to $243 billion in 2025, soaring to $400 billion to $590 billion by 2034 or 2037, depending...

Rare Disease Drugs Market Overview The global Rare Disease Drugs Market size is expected to grow from USD 179.5 billion in 2025 to USD 364.1 billion by 2033, expanding at a CAGR of 9.6% during the forecast period. Rare diseases, defined by their low prevalence, often lack sufficient treatment options and are frequently overlooked in traditional drug development pipelines. However,...

"Regional Overview of Executive Summary Rett Syndrome Market by Size and Share The global Rett syndrome market size was valued at USD 35.34 billion in 2024 and is projected to reach USD 3,130.02 billion by 2032, with a CAGR of 75.15% during the forecast period of 2025 to 2032. Deliberately analyzed facts and figures of the market and keen business insights mentioned in Rett Syndrome...

The South Korea blastic plasmacytoid dendritic cell neoplasm (BPDCN) market, valued at USD 42.88 million in 2024, is forecast to expand at a compound annual growth rate (CAGR) of 7.20% between 2025 and 2034, reaching an estimated USD 85.78 million by 2034. Growth will be propelled by improved disease awareness, advancements in targeted therapies, wider diagnostic...

Ultomiris Drug Market: Driving Innovation in Rare Disease Treatment The global pharmaceutical landscape has been witnessing significant advancements in recent years, particularly in the treatment of rare and ultra-rare diseases. One such breakthrough therapy that has gained attention is Ultomiris (ravulizumab-cwvz), developed by Alexion Pharmaceuticals (now part of AstraZeneca). As...

Ultomiris Drug Market: Growth Opportunities, Trends, and Future Outlook The global pharmaceutical industry has been witnessing a surge in innovative treatments for rare diseases, with biologics and specialty drugs leading the transformation. Among them, Ultomiris (ravulizumab-cwvz), developed by Alexion Pharmaceuticals (now part of AstraZeneca), has emerged as a game-changing...